$VXRT I'm wondering how many people here believe there will even be a P3, assuming positive data for 2a and 2b? P3 would not even begin until next summer, therefore ending late 2022/early 2023. Does anyone believe Dr. Cummings came on board for this timeline? This is not a rhetorical question, I'm genuinely curious about this. Am I the only one believing that the 800 subjects for 2b will be sufficient for efficacy purposes? I believe this is why they put so much time and thought into dosing and the 2 constructs. Maybe they intend to go into foreign markets after 2b and do the P3 for the FDA here. Given that part of 2b will be in India, will Vaxy (without a product on the market and with no revenue) be able to say no to a desperate country that wants to buy hundreds of millions of their pills?
6
17
17 Likes